netFormulary Leeds Formulary NHS
Leeds Teaching Hospitals NHS Trust
Leeds and York Partnership NHS Foundation Trust
Leeds Community Healthcare NHS Trust
NHS Leeds CCG
 
 Introduction

Welcome to the Leeds Medicines Formulary

Useful Links

meandmymedicines

Information on medicines for patients and carers

NHS.uk Medicines A to Z

Medicines for Children

 Adult BNF
 Paediatric BNF
BNF Apps (iOS and Android) 

Further Medicines Management Resources

NHS Leeds Traffic Light List

Antimicrobial guidelines

Compliance with NICE technology appraisals

otcmedicines

 

News Feed

MHRA: Drug Safety Update(March 2020): Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression


MHRA: Drug Safety Update(March 2020): SGLT2 inhibitors: monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness


 MHRA: Drug Safety Update (March2020): Baricitinib (Olumiant▼): risk of venous thromboembolism


MHRA: Drug Saftey Update (March 2020): Tofacitinib (Xeljanz▼): new measures to minimise risk of venous thromboembolism and of serious and fatal infections


MHRA:Drug Safety Update (March 2020): Esmya (ulipristal acetate): suspension of the licence due to risk of serious liver injury

 


COVID-19: useful links


>>> more news

Leeds Secondary Care Links

  LTHT Injectable Medicines Guides (Medusa)
Adult IV monographs
Paediatric IV monographs     .

 


NetFormulary
   Last updated: 02/04/2020 11:11:28.